933786-79-9 Usage
Description
(4-(4-(TrifluoroMethyl)phenoxy)phenyl)Methanol is a phenylmethanol chemical compound characterized by a phenyl ring with a trifluoromethyl group attached to one of the phenyl rings and a methanol group attached to the other phenyl ring. This unique structure and reactivity make it valuable for various applications in organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
(4-(4-(TrifluoroMethyl)phenoxy)phenyl)Methanol is used as a building block for the synthesis of complex organic molecules, taking advantage of its unique structure and reactivity.
Used in Pharmaceutical Research:
(4-(4-(TrifluoroMethyl)phenoxy)phenyl)Methanol is used as a starting material in the development of new drugs, particularly due to its trifluoromethyl group, which is valuable for medicinal chemistry and the development of bioactive molecules.
Used in Medicinal Chemistry:
(4-(4-(TrifluoroMethyl)phenoxy)phenyl)Methanol is used as a key intermediate in the synthesis of various bioactive molecules, contributing to the advancement of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 933786-79-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,7,8 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 933786-79:
(8*9)+(7*3)+(6*3)+(5*7)+(4*8)+(3*6)+(2*7)+(1*9)=219
219 % 10 = 9
So 933786-79-9 is a valid CAS Registry Number.
933786-79-9Relevant articles and documents
Synthesis and Structure-Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6 S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5 H -imidazo[2,1- b ][1,3]oxazine (PA-824)
Palmer, Brian D.,Sutherland, Hamish S.,Blaser, Adrian,Kmentova, Iveta,Franzblau, Scott G.,Wan, Baojie,Wang, Yuehong,Ma, Zhenkun,Denny, William A.,Thompson, Andrew M.
, p. 3036 - 3059 (2015/04/27)
Novel extended side chain nitroimidazooxazine analogues featuring diverse linker groups between two aryl rings were studied as a potential strategy to improve solubility and oral activity against chronic infection by Mycobacterium tuberculosis. Both lipop
2,6-DISUBSTITUTED PYRIDINES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS
-
Page/Page column 64, (2009/07/17)
Disclosed are compounds of formula (I) wherein R1 and R2 are independently selected from hydrogen, halo, CF3, C1-4alkyl and allyl; Y represents (II), (III), (IV) or (V) wherein R3 represents CF3 or C1-4alkyl; and R3a represents CF3 or C1-4alkyl.
